Recursion Pharmaceuticals Inc
Biotechnology
Healthcare
RXRX
403 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
5.01
52 week high
10.87
high
5.13
52 week low
0.00
low
4.80
growth
-29.26 %
previous Close
4.98
P/E ratio
market cap
2.40 B
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
18.00 %
eps surprise
-16.05 %
net profit margin
0.00 %
1373.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top